Top Markets
Coin of the day
Aerovate Therapeutics, Inc. Aerovate Therapeutics, Inc.

Aerovate Therapeutics, Inc.

AVTE
주식 순위 #5459
Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise... Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise focused on innovating therapies to enhance the well-being of patients afflicted with rare cardiopulmonary illnesses across the United States. The company's principal effort involves advancing AV-101, an inhaled dry powder variant of imatinib, which is currently undergoing a Phase 2b/Phase 3 clinical study for the management of pulmonary arterial hypertension. Established in 2018, Aerovate Therapeutics, Inc. maintains its corporate headquarters in Waltham, Massachusetts.
주가
$93.80
마지막 동기화: 2025-04-28
시가총액
$2.68B
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Aerovate Therapeutics, Inc. (AVTE)

카테고리

Aerovate Therapeutics, Inc. (AVTE)의 EPS
June 2026 기준 EPS TTM: $-3.65K
Aerovate Therapeutics, Inc.의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $-3.65K입니다. 2023년 말에는 회사의 EPS가 $-2.87였으며, 이는 2022년의 EPS $-2.10와 증가입니다.
Aerovate Therapeutics, Inc.의 EPS 기록 (2019 ~ 2026)
매년 말의 EPS
연도 EPS 변화
2026 (TTM) $-3.65K 149,412.70%
2024 $-2.44 -14.98%
2023 $-2.87 36.67%
2022 $-2.10 12.30%
2021 $-1.87 -95.34%
2020 $-40.17 28,592.86%
2019 $-0.14 0.00%
유사 기업 또는 경쟁사의 EPS
회사 EPS EPS 차이 국가
$17.32 -100.47%
US
$27.74 -100.76%
NL
$-7.98 -99.78%
US
$-5.29 -99.85%
AU
- -
CH